Correlation Between Assembly Biosciences and Dominari Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Assembly Biosciences and Dominari Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assembly Biosciences and Dominari Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Assembly Biosciences and Dominari Holdings, you can compare the effects of market volatilities on Assembly Biosciences and Dominari Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assembly Biosciences with a short position of Dominari Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assembly Biosciences and Dominari Holdings.

Diversification Opportunities for Assembly Biosciences and Dominari Holdings

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between Assembly and Dominari is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Assembly Biosciences and Dominari Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dominari Holdings and Assembly Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assembly Biosciences are associated (or correlated) with Dominari Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dominari Holdings has no effect on the direction of Assembly Biosciences i.e., Assembly Biosciences and Dominari Holdings go up and down completely randomly.

Pair Corralation between Assembly Biosciences and Dominari Holdings

Given the investment horizon of 90 days Assembly Biosciences is expected to under-perform the Dominari Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Assembly Biosciences is 2.37 times less risky than Dominari Holdings. The stock trades about -0.04 of its potential returns per unit of risk. The Dominari Holdings is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  169.00  in Dominari Holdings on November 1, 2024 and sell it today you would earn a total of  189.00  from holding Dominari Holdings or generate 111.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Assembly Biosciences  vs.  Dominari Holdings

 Performance 
       Timeline  
Assembly Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Assembly Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Dominari Holdings 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Dominari Holdings are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak primary indicators, Dominari Holdings demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Assembly Biosciences and Dominari Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Assembly Biosciences and Dominari Holdings

The main advantage of trading using opposite Assembly Biosciences and Dominari Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assembly Biosciences position performs unexpectedly, Dominari Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dominari Holdings will offset losses from the drop in Dominari Holdings' long position.
The idea behind Assembly Biosciences and Dominari Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios